Important CYP2D6-inhibiting drugs are, for instance, selective serotonin reuptake inhibitors (SSRIs), which may be used in breast cancer patients to treat depression or hot flashes; a common side effect of tamoxifen (Loprinzi et al, 2000). This evidence concerns the gene CYP2D6 and breast cancer.